Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0070
0.00 (0.00%)
Jun 20, 2024, 12:00 AM EDT - Market closed

Baudax Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20222021202020192018 2017
Net Income
-58.8-19.77-76.1-32.56-73.67
Upgrade
Depreciation & Amortization
2.162.822.550.480.4
Upgrade
Share-Based Compensation
1.44.799.345.464.57
Upgrade
Other Operating Activities
27.44-37.1120.15-23.438.95
Upgrade
Operating Cash Flow
-27.79-49.27-44.06-50.04-59.75
Upgrade
Capital Expenditures
-0.02-0.2-0.64-1.48-3.45
Upgrade
Change in Investments
00.01000
Upgrade
Investing Cash Flow
-0.02-0.19-0.64-1.48-3.45
Upgrade
Share Issuance / Repurchase
20.8342.8850.8200
Upgrade
Debt Issued / Paid
-2.45010.0400
Upgrade
Other Financing Activities
-1.2-7.87-3.5669.2763.2
Upgrade
Financing Cash Flow
17.1835.0157.369.2763.2
Upgrade
Net Cash Flow
-10.63-14.4512.617.740
Upgrade
Free Cash Flow
-27.81-49.47-44.7-51.53-63.2
Upgrade
Free Cash Flow Margin
-2191.73%-4580.83%-9066.33%--
Upgrade
Free Cash Flow Per Share
-83.87-903.82-3356.64-7714.85-9462.84
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).